Status:
UNKNOWN
Voice Analysis in Women With Polycystic Ovary Syndrome
Lead Sponsor:
Minia University
Conditions:
Voice Change
Eligibility:
FEMALE
20-35 years
Brief Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to one in five reproductive-aged women. It is associated with clinical and/or biochemical hyperandrogenism, oligomenorrhea...
Detailed Description
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to one in five reproductive-aged women. It is associated with clinical and/or biochemical hyperandrogenism, oligomenorrhea...
Eligibility Criteria
Inclusion
- Group I participants:
- women with polycystic ovaries on ultrasound.
- Group II will be:
- women have a regular menstrual cycles and no PCOS on ultrasound
Exclusion
- Women with hypersensitive gag reflex,
- alcohol consumption,
- Smoking,
- reflux symptoms and vocal abuse will be excluded in both groups.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06085170
Start Date
December 1 2023
End Date
February 1 2024
Last Update
October 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.